Author

Evi Lianidou

NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS - Cited by 10,490 - Liquid Biopsy - Circulating Tumor Cells - ctDNA - molecular diagnostics - Clinical Chemistry

Biography

Evi Lianidou is working in the Laboratory of Analytical Chemistry of Chemistry Department in the University of Athen located in Athens ,Greece. Her research interests are Liquid Biopsy, Circulating Tumor Cells, ctDNA, molecular diagnostics, Clinical Chemistry.
Title
Cited by
Year
SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions
A Galani, R Aalizadeh, M Kostakis, A Markou, N Alygizakis, T Lytras, ...Science of The Total Environment 804, 150151, 2022202
74
2022
41
2021
The potential of liquid biopsy in the management of cancer patients
A Markou, E Tzanikou, E LianidouSeminars in cancer biology 84, 69-79, 2022202
27
2022
Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients
A Ntzifa, A Strati, G Kallergi, A Kotsakis, V Georgoulias, E LianidouScientific Reports 11 (1), 2313, 2021202
26
2021
KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer
S Mastoraki, I Balgkouranidou, E Tsaroucha, A Klinakis, V Georgoulias, ...Molecular Oncology (9), 2412-2422, 2021202
15
2021
What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology?–Considerations on pre-analytical aspects by the IFCC workgroup cfDNA
R Danesi, YMD Lo, M Oellerich, J Beck, S Galbiati, M Del Re, E Lianidou, ...Clinica Chimica Acta 520, 168-171, 2021202
15
2021
Development and Analytical Validation of a Reverse Transcription Droplet Digital PCR (RT-ddPCR) Assay for PD-L1 Transcripts in Circulating Tumor Cells
A Strati, M Zavridou, P Economopoulou, S Gkolfinopoulos, A Psyrri, ...Clinical Chemistry 67 (4), 642-652, 2021202
12
2021
Prognostic role of RASSF1A, SOX17 and Wif-1 promoter methylation status in cell-free DNA of advanced gastric cancer patients
EI Karamitrousis, I Balgkouranidou, N Xenidis, K Amarantidis, E Biziota, ...Technology in cancer research & treatment 20, 1533033820973279, 2021202
12
2021
SARS-CoV-2 infection is asymptomatic in nearly half of adults with robust anti-spike protein receptor-binding domain antibody response
OE Tsitsilonis, D Paraskevis, E Lianidou, E Terpos, A Akalestos, V Pierros, ...Vaccines 9 (3), 207, 2021202
11
2021
RNA-based CTC analysis provides prognostic information in metastatic breast cancer
A Strati, M Nikolaou, V Georgoulias, ES LianidouDiagnostics 11 (3), 513, 2021202
9
2021
Evaluation of Monocarboxylate Transporter 4 (MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non …
A Markou, E Tzanikou, G Kallergi, E Pantazaka, V Georgoulias, ...Frontiers in Cell and Developmental Biology , 64178, 2021202
9
2021
Evaluation of viral concentration and extraction methods for SARS-CoV-2 recovery from wastewater using droplet digital and quantitative RT-PCR
L Dimitrakopoulos, A Kontou, A Strati, A Galani, M Kostakis, V Kapes, ...Case Studies in Chemical and Environmental Engineering 6, 100224, 2022202
8
2022
A comprehensive molecular analysis of in vivo isolated EpCAM-positive circulating tumor cells in breast cancer
A Strati, M Zavridou, G Kallergi, E Politaki, A Kuske, TM Gorges, ...Clinical Chemistry 67 (10), 1395-1405, 2021202
8
2021
Blood transcriptomes of anti-SARS-CoV-2 antibody-positive healthy individuals who experienced asymptomatic versus clinical infection
PP Sfikakis, KM Verrou, G Ampatziadis-Michailidis, O Tsitsilonis, ...Frontiers in Immunology 12, 746203, 2021202
8
2021
Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies
Determination of MYDL265P mutation fraction in IgM monoclonal gammopathiesT Bagratuni, A Markou, D Patseas, N Mavrianou-Koutsoukou, F Aktypi, ...Blood Advances 6 (1), 19-199, 2022202
8
2022
Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer
V Tserpeli, D Stergiopoulou, D Londra, L Giannopoulou, P Buderath, ...Cancers 14 (1), 4, 2021202
6
2021
The value proposition of integrative diagnostics for (early) detection of cancer. On behalf of the EFLM interdisciplinary Task and Finish Group “CNAPS/CTC for early detection …
MF Froelich, E Capoluongo, Z Kovacs, SJ Patton, ES Lianidou, ...Clinical Chemistry and Laboratory Medicine (CCLM) 0 (), 821-829, 2022202
6
2022